Growth Metrics

Lifecore Biomedical (LFCR) Profit After Tax: 2009-2025

Historic Profit After Tax for Lifecore Biomedical (LFCR) over the last 16 years, with May 2025 value amounting to -$1.1 million.

  • Lifecore Biomedical's Profit After Tax rose 83.81% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was -$38.7 million, marking a year-over-year decrease of 480.29%. This contributed to the annual value of -$38.7 million for FY2025, which is 422.29% down from last year.
  • Latest data reveals that Lifecore Biomedical reported Profit After Tax of -$1.1 million as of Q2 2025, which was up 92.23% from -$14.8 million recorded in Q1 2025.
  • In the past 5 years, Lifecore Biomedical's Profit After Tax registered a high of $15.6 million during Q1 2024, and its lowest value of -$38.5 million during Q4 2021.
  • Over the past 3 years, Lifecore Biomedical's median Profit After Tax value was -$9.8 million (recorded in 2023), while the average stood at -$10.2 million.
  • Within the past 5 years, the most significant YoY rise in Lifecore Biomedical's Profit After Tax was 211.21% (2023), while the steepest drop was 919.23% (2023).
  • Quarterly analysis of 5 years shows Lifecore Biomedical's Profit After Tax stood at -$38.5 million in 2021, then skyrocketed by 66.71% to -$12.8 million in 2022, then soared by 211.21% to $14.2 million in 2023, then crashed by 146.14% to -$6.6 million in 2024, then soared by 83.81% to -$1.1 million in 2025.
  • Its Profit After Tax stands at -$1.1 million for Q2 2025, versus -$14.8 million for Q1 2025 and -$6.6 million for Q4 2024.